31 Mar 2020 - The Australian share market had a positive start to the session, up almost 3 per cent at noon, then fell sharply in the second half of trade erasing the days gain to finish 2 per cent down.
31 Mar 2020 - The Australian share market opened higher again this morning and is now trading 2.8 per cent higher. Virgin Australia (ASX:VAH) has gone into a trading halt as it seeks financial support from the Federal Government.
31 Mar 2020 - Worley (ASX:WOR) has been awarded an extension to an existing services contract with Chevron Australia.
31 Mar 2020 - G8 Education (ASX:GEM) has postponed the payment of its fully franked final dividend until the end of October.
31 Mar 2020 - Wesfarmers (ASX:WES) today announced that trades have been executed for the sale of 5.2 per cent of the issued capital in Coles Group (ASX:COL) for $1.06 billion.
31 Mar 2020 - Rare earths producer Lynas Corporation (ASX:LYC) is continuously assessing the effects of the shutdown of their Malaysia plant on the essential supply chains to which they contribute after an closure extension ordered by the government to help to help reduce the spread of COVD-19.
31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.
31 Mar 2020 - We saw a surge on the markets yesterday closing 7% higher – this movement is expected to continue with the ASX expected to open higher this morning. European governments moved to tighten restrictions to contain the coronavirus outbreak with an unrelenting rise in infections and deaths. Air New Zealand (ASX:AIZ) will begin reducing its workforce from this week as the severe economic impact of COVID-19 hits the airline.
31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform.
30 Mar 2020 - It has been a mostly positive day of trade for the ASX after managing to gain momentum the local bourse managed to close 7% higher. Mayne Pharma (ASX:MYX) shares saw a rise today. Cyclopharm, (ASX:CYC) through its subsidary Cyclomedica Australia, has lodged its New Drug Application (NDA) for Technegas, a nuclear medicine functional lung ventilation imaging agent, with the United States Food and Drug Administration (USFDA).